Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer

British Journal of Surgery

Volumn 100, Issue 11, 2013, Pages 1421-1429

  De Bruijn, K M J ^a   Arends, L R ^b   Hansen, B E ^a   Leeflang, S ^c   Ruiter, R ^a   Van Eijck, C H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; COLORECTAL TUMOR; DIABETES MELLITUS; EPIDEMIOLOGY; FEMALE; HUMAN; META ANALYSIS; MIDDLE AGED; MORTALITY; REVIEW;

BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DIABETES COMPLICATIONS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MIDDLE AGED;

EID: 84883486166     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9229     Document Type: Review

References (53)

1. Felber JP, Golay A,. Pathways from obesity to diabetes. Int J Obes Relat Metab Disord 2002; 26 (Suppl 2): S39-S45.
2. Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, et al., Obesity and severe obesity forecasts through 2030. Am J Prev Med 2012; 42: 563-570.
3. DeMaria EJ, Carmody BJ,. Perioperative management of special populations: obesity. Surg Clin North Am 2005; 85: 1283-1289, xii.
4. Turina M, Christ-Crain M, Polk HC Jr,. Impact of diabetes mellitus and metabolic disorders. Surg Clin North Am 2005; 85: 1153-1161, ix.
5. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al., Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-1685.
6. Suh S, Kim KW,. Diabetes and cancer: is diabetes causally related to cancer? Diabetes Metab J 2011; 35: 193-198.
7. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al., Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008; 300: 2754-2764.
8. Nicolucci A., Epidemiological aspects of neoplasms in diabetes. Acta Diabetol 2010; 47: 87-95.
9. Cohen DH, LeRoith D,. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer 2012; 19: F27-F45.
10. Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, et al., Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 2007; 92: 1510-1516.
11. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, et al., Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol 2010; 24: 1441-1452.
12. Guertin DA, Sabatini DM,. Defining the role of mTOR in cancer. Cancer Cell 2007; 12: 9-22.
13. Mahid SS, Hornung CA, Minor KS, Turina M, Galandiuk S,. Systematic reviews and meta-analysis for the surgeon scientist. Br J Surg 2006; 93: 1315-1324.
14. Oxford Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. http://www.cebm.net/mod- product/design/graphics/CEBM-Levels-of-Evidence-2.1.gif [accessed 25 July 2012].
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
16. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp [accessed 3 May 2013].
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
18. Redaniel MT, Jeffreys M, May MT, Ben-Shlomo Y, Martin RM,. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women. Cancer Causes Control 2012; 23: 1785-1795.
19. Yeh HC, Platz EA, Wang NY, Visvanathan K, Helzlsouer KJ, Brancati FL,. A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care 2012; 35: 113-118.
20. van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE,. Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia 2012; 55: 2163-2172.
21. Miao Jonasson J, Cederholm J, Eliasson B, Zethelius B, Eeg-Olofsson K, Gudbjornsdottir S,. HbA1C and cancer risk in patients with type 2 diabetes-a nationwide population-based prospective cohort study in Sweden. PLoS One 2012; 7: e38784.
22. Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT,. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 2012; 30: 53-59.
23. Dankner R, Shanik MH, Keinan-Boker L, Cohen C, Chetrit A,. Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study. Diabetes Care 2012; 35: 1538-1543.
24. Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K,. The impact of type 2 diabetes mellitus on cancer-specific survival: a follow-up study in Sweden. Cancer 2012; 118: 1353-1361.
25. Stefansdottir G, Zoungas S, Chalmers J, Kengne AP, Knol MJ, Leufkens HGM, et al., Intensive glucose control and risk of cancer in patients with type 2 diabetes. Diabetologia 2011; 54: 1608-1614.
26. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al.,; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829-841.
27. Morrison DS, Batty GD, Kivimaki M, Davey Smith G, Marmot M, Shipley M,. Risk factors for colonic and rectal cancer mortality: evidence from 40 years' follow-up in the Whitehall I study. J Epidemiol Community Health 2011; 65: 1053-1058.
28. Lam EK, Batty GD, Huxley RR, Martiniuk AL, Barzi F, Lam TH, et al., Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. Ann Oncol 2011; 22: 730-738.
29. Irwin ML, Duggan C, Wang CY, Smith AW, McTiernan A, Baumgartner RN, et al., Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol 2011; 29: 47-53.
30. Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, et al., Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol 2011; 29: 54-60.
31. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, et al., Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol 2011; 29: 32-39.
32. Zhou XH, Qiao Q, Zethelius B, Pyörälä K, Söderberg S, Pajak A, et al.,; DECODE Study Group. Diabetes, prediabetes and cancer mortality. Diabetologia 2010; 53: 1867-1876.
33. He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA,. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort. Br J Cancer 2010; 103: 120-126.
34. Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, et al., Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 2010; 139: 1138-1146.
35. Flood A, Strayer L, Schairer C, Schatzkin A,. Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 2010; 21: 1277-1284.
36. Ogunleye AA, Ogston SA, Morris AD, Evans JMM,. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009; 101: 1199-1201.
37. Van De Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR,. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 2007; 120: 1986-1992.
38. Liao S, Li J, Wei W, Wang L, Zhang Y, Wang C, et al. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev 2011; 12: 1061-1065.
39. Deng L, Gui Z, Zhao L, Wang J, Shen L,. Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 2012; 57: 1576-1585.
40. Larsson SC, Mantzoros CS, Wolk A,. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007; 121: 856-862.
41. Larsson SC, Orsini N, Wolk A,. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687.
42. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA,. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 2011; 106: 1911-1921.
43. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA,. Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 2012; 23: 967-981.
44. Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J,. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 2011; 26: 863-876.
45. Peairs KS, Barone BB, Snyder CF, Yeh HC, Stein KB, Derr RL, et al., Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 2011; 29: 40-46.
46. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W,. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95: 1797-1800.
47. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K,. Cancer risk among patients hospitalized for type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med 2010; 27: 791-797.
48. Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH, Kim WH,. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer 2012; 131: 752-759.
49. Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL,. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care 2012; 35: 299-304.
50. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR,. Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 2010; 33: 1304-1308.
51. Chang CH, Lin JW, Wu LC, Lai MS, Chuang LM,. Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus. J Clin Endocrinol Metab 2012; 97: E1170-E1175.
52. Carstensen B, Witte DR, Friis S,. Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia 2012; 55: 948-958.
53. Altman DG,. Practical Statistics for Medical Research. Chapman & Hall: London, 1991.